Benitec Biopharma Inc. Common Stock

BNTCNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
12.88 USD
↘ 0.14 (1.08%)AT CLOSE (11:59 AM EDT)
12.87
↘ 0.01 (0.08%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
12.87
↘ 0.01 (0.08%)
🔴Market: CLOSED

BNTC is currently priced at $12.87. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest BNTC is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 26, 2026.

Open?$13.02
High?$13.02
Low?$12.65
Prev. Close?$13.02
Volume?64.7K
Avg. Volume?152.1K
VWAP?$12.81
Rel. Volume?0.43x
Bid / Ask
Bid?$11.11 × 200
Ask?$13.22 × 300
Spread?$2.11
Midpoint?$12.17
Valuation & Ratios
Market Cap?442.5M
Shares Out?34.4M
Float?21.1M
Float %?61.4%
P/E Ratio?N/A
P/B Ratio?2.41
EPS?-$1.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
19
Market Cap
447.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.benitec.com
Listed
2012-07-11
Address
3940 TRUST WAY
HAYWARD, CA 94545
Phone: (510) 780-0819
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?71.43Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.99%Elevated
Short Interest?2.1M
Days to Cover?9.9
Free Float21.1M
Avg Daily Volume212.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?56.82Strong
Quick Ratio?56.82Strong
Cash Ratio?56.43Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
66
2.41CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-26.7%WEAK▾
ROA?
S&P
3
-26.1%WEAK▾
Cash Flow & Enterprise
FCF?$-19818000
Enterprise Value?$257.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist